Biotech & PharmaNovo Nordisk Exits Internal Parkinson's Research, Handing Discovery to AI Partner as NVIDIA's BioNeMo Becomes Global Pharma InfrastructureSalvado•Jun 25, 2026
Biotech & PharmaSix FDA Oncology Decisions Due in 2026 — ADCs, Cell Therapies, and Checkpoint Inhibitors Face Global Catalyst CalendarSalvado•Jun 19, 2026
Pharmaceuticals & BiotechFDA's H2 2026 Drug Decision Cluster Triggers Global Biotech Repricing in ADCs and Cell TherapiesSalvado•Jun 17, 2026
biotechnologyFDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in DealsSalvado•Apr 16, 2026
biotechnologyArtiva Biotherapeutics faces $50-150M capital gap as NK cell therapy trials advanceViaNews Editorial Team•Mar 7, 2026
Biotechnology & Life SciencesThe Fragile Chain: How One Logistics Provider's 701-Trial Backlog Exposes a Global Cell Therapy BottleneckViaNews Editorial Team•Feb 18, 2026
Health & ScienceCellectis Bets on Off-the-Shelf CAR-T Revolution as $700M Peak Sales Forecast Puts Global Cell Therapy Race in FocusViaNews Editorial Team•Feb 18, 2026
